These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19196557)

  • 1. Antiviral treatment for hepatitis C virus infection: effectiveness at general population level in a highly endemic area.
    Mariano A; Caserta C; Pendino GM; Vacalebre C; Surace P; Fiorillo MT; Polito I; Surace M; Alicante S; Amante A; Foti G; Marra M; Gutamo G; Amato F; Messineo A; Mele A
    Dig Liver Dis; 2009 Jul; 41(7):509-15. PubMed ID: 19196557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C; Federico A; Masarone M; Torella R; Blanco Cdel V; Persico M
    Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis C genotypes in Indian patients and their clinical significance.
    Amarapurkar D; Dhorda M; Kirpalani A; Amarapurkar A; Kankonkar S
    J Assoc Physicians India; 2001 Oct; 49():983-5. PubMed ID: 11848330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study.
    Hansen N; Obel N; Christensen PB; Krarup H; Laursen AL; Clausen MR; Lunding S; Møller A; Schlichting P; Kromann-Andersen H; Bukh J; Weis N;
    J Viral Hepat; 2009 Sep; 16(9):659-65. PubMed ID: 19486467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
    Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
    J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin.
    Vukotic R; Gramenzi A; Vitale G; Cursaro C; Serra C; Biselli M; Scuteri A; Andreone P; Bernardi M
    Liver Int; 2008 Mar; 28(3):407-11. PubMed ID: 17900241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
    de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
    Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
    Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of chronic hepatitis C.
    Sharara AI
    J Med Liban; 1999; 47(6):339-42. PubMed ID: 10758707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
    Bini EJ; Bräu N; Currie S; Shen H; Anand BS; Hu KQ; Jeffers L; Ho SB; Johnson D; Schmidt WN; King P; Cheung R; Morgan TR; Awad J; Pedrosa M; Chang KM; Aytaman A; Simon F; Hagedorn C; Moseley R; Ahmad J; Mendenhall C; Waters B; Strader D; Sasaki AW; Rossi S; Wright TL
    Am J Gastroenterol; 2005 Aug; 100(8):1772-9. PubMed ID: 16086714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating hepatitis C infection in liver transplant recipients.
    Terrault NA; Berenguer M
    Liver Transpl; 2006 Aug; 12(8):1192-204. PubMed ID: 16868944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
    Sulkowski MS; Mehta SH; Torbenson MS; Higgins Y; Brinkley SC; de Oca RM; Moore RD; Afdhal NH; Thomas DL
    AIDS; 2007 Oct; 21(16):2209-16. PubMed ID: 18090048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment.
    Fleming CA; Craven DE; Thornton D; Tumilty S; Nunes D
    Clin Infect Dis; 2003 Jan; 36(1):97-100. PubMed ID: 12491208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.
    La Mura V; De Renzo A; Perna F; D'Agostino D; Masarone M; Romano M; Bruno S; Torella R; Persico M
    J Hepatol; 2008 Oct; 49(4):557-63. PubMed ID: 18678434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribavirin priming in patients with chronic hepatitis C and normal ALT: a pilot study.
    Töx U; Schulte S; Heindl B; Goeser T; Drebber U; Stelzer A; Steffen HM
    Hepatogastroenterology; 2008; 55(86-87):1666-70. PubMed ID: 19102366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine protease inhibitors as anti-hepatitis C virus agents.
    Reiser M; Timm J
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohort.
    Freudenreich O; Gandhi RT; Walsh JP; Henderson DC; Goff DC
    Psychosomatics; 2007; 48(5):405-11. PubMed ID: 17878499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of 24-week interferon monotherapy for type C liver cirrhosis in Japanese patients with genotype 1b and low virus load.
    Arase Y; Suzuki F; Sezaki H; Kawamura Y; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Yatsuji H; Hirakawa M; Kobayashi M; Ikeda K; Kumada H
    Intervirology; 2008; 51(4):265-9. PubMed ID: 18841028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hepatitis C: an age wave of disease burden.
    McHutchison JG; Bacon BR
    Am J Manag Care; 2005 Oct; 11(10 Suppl):S286-95; quiz S307-11. PubMed ID: 16232012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is chronic hepatitis C treatment as efficient in the general population as in randomised trials?].
    Hatem C; Jooste V; Minello A; Evrard P; Obert B; Bresson Hadni S; Miguet JP; Faivre J; Bonithon C; Hillon P; ;
    Gastroenterol Clin Biol; 2003; 27(8-9):732-7. PubMed ID: 14586246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.